FDA Import Refusal SCS-3621753-0/11/1 — Novo Nordisk Canada Inc
The FDA refused shipment SCS-3621753-0/11/1 from Novo Nordisk Canada Inc (Canada) on Sep 20, 2022. The refused product falls under Drugs and Biologics — MISCELLANEOUS PATENT MEDICINES, ETC.. Cited charge: 75 This firm has 3 other import refusals on record.
Refusal details
- Date
- Sep 20, 2022
- Country
- Canada
- Product Category
- Drugs and Biologics
- Product Code
- 66VCY99 MISCELLANEOUS PATENT MEDICINES, ETC.
- Charges
- 75